ArticleJournal for immunotherapy of cancer2018

Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors.

Edward Hammond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.